Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10 | 320 | 620 | 1,120 | 1,550 |
| Other current assets | 20 | 10 | 0 | 0 | 10 |
| TOTAL | $30 | $330 | $620 | $1,120 | $1,560 |
| Non-Current Assets | |||||
| PPE Net | 110 | N/A | N/A | N/A | 80 |
| Other Non-Current Assets | 157 | 150 | 150 | 100 | 100 |
| TOTAL | $267 | $150 | $150 | $100 | $180 |
| Total Assets | $270 | $570 | $840 | $1,300 | $1,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 160 | 170 | 120 | 90 | 210 |
| Accrued Expenses | 260 | 150 | 90 | 120 | 0 |
| Other current liabilities | 0 | 0 | 0 | 0 | 10 |
| TOTAL | $430 | $320 | $210 | $210 | $220 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 40 | 40 | 10 | 10 | 0 |
| TOTAL | $40 | $40 | $10 | $10 | $N/A |
| Total Liabilities | $480 | $370 | $230 | $220 | $220 |
| Shareholders' Equity | |||||
| Common Shares | 70 | 70 | 70 | 70 | 70 |
| Retained earnings | -5,490 | -5,070 | -4,620 | -4,120 | -3,610 |
| Other shareholders' equity | -240 | -270 | -160 | -240 | -180 |
| TOTAL | $-200 | $200 | $610 | $1,080 | $1,510 |
| Total Liabilities And Equity | $280 | $570 | $840 | $1,300 | $1,730 |